 | Newsflash: AC Immune SA (NASDAQ:ACIU) Analysts Have Been Trimming Their Revenue Forecasts
finance.yahoo.com - April 4 at 5:07 PM |
 | SVB Leerink Comments on AC Immune SA's Q1 2020 Earnings (NASDAQ:ACIU)
www.americanbankingnews.com - April 3 at 7:17 AM |
| AC Immune Presents the Latest Preclinical Data on Novel Drug Targets for Neurodegenerative Diseases
finance.yahoo.com - April 2 at 4:57 PM |
| AC Immune (NASDAQ:ACIU) Releases Quarterly Earnings Results, Misses Estimates By $0.06 EPS
www.americanbankingnews.com - March 31 at 7:50 AM |
 | AC Immune EPS misses by CHF0.03, misses on revenue
seekingalpha.com - March 30 at 8:20 PM |
| AC Immune Reports Full-Year 2019 Financial Results and Provides 2020 R&D Outlook
finance.yahoo.com - March 30 at 7:09 AM |
| Analysts Anticipate AC Immune SA (NASDAQ:ACIU) Will Announce Quarterly Sales of $3.57 Million
www.americanbankingnews.com - March 27 at 5:20 AM |
| Analysts Expect AC Immune SA (NASDAQ:ACIU) Will Announce Earnings of -$0.22 Per Share
www.americanbankingnews.com - March 25 at 3:14 AM |
| AC Immune earns second Morphomer Tau milestone from Lilly
seekingalpha.com - March 23 at 1:56 PM |
 | Internationally Renowned Neurologist Dr. Juan Fortea Joins AC Immune's Clinical Advisory Board
www.marketwatch.com - March 20 at 8:16 AM |
| Internationally Renowned Neurologist Dr. Juan Fortea Joins AC Immune’s Clinical Advisory Board
finance.yahoo.com - March 20 at 8:16 AM |
| Moderna (MRNA) Catches Eye: Stock Jumps 6.4%
finance.yahoo.com - March 18 at 1:06 PM |
| Head to Head Comparison: Takeda Pharmaceutical (OTCMKTS:TKPYY) versus AC Immune (OTCMKTS:ACIU)
www.americanbankingnews.com - March 18 at 9:00 AM |
| AC Immune SA (NASDAQ:ACIU) Short Interest Up 18.0% in February
www.americanbankingnews.com - March 13 at 4:00 AM |
 | Four presentations at AAT-AD/PD™ focus meeting
www.globenewswire.com - March 5 at 11:38 AM |
| AC Immune to Present New Data Demonstrating the Depth of its Neurodegenerative Programs at the Upcoming Advances in Alzheimer’s and Parkinson’s Therapies Focus Meeting
finance.yahoo.com - March 5 at 11:38 AM |
| Is AC Immune SA's (NASDAQ:ACIU) CEO Pay Justified?
finance.yahoo.com - February 24 at 8:04 AM |
| AC Immune SA (NASDAQ:ACIU) Has A ROE Of 17%
finance.yahoo.com - December 24 at 8:50 AM |
| Did Hedge Funds Drop The Ball On AC Immune SA (ACIU) ?
finance.yahoo.com - December 16 at 5:39 PM |
| AC Immune to Present at Jefferies 2019 London Healthcare Conference
finance.yahoo.com - November 14 at 9:03 AM |
| AC Immune Q3 2019 Financial Results and Business Update
finance.yahoo.com - November 13 at 7:57 AM |
| AC Immune Hosts Key Opinion Leader Event: 'Untangling' Tau Pathology to Treat Alzheimer's and Neurodegenerative Diseases
www.marketwatch.com - November 6 at 7:01 PM |
| Were Hedge Funds Right About Souring On AC Immune SA (ACIU)?
finance.yahoo.com - November 6 at 7:01 PM |
| AC Immune Hosts Key Opinion Leader Event: ‘Untangling’ Tau Pathology to Treat Alzheimer’s and Neurodegenerative Diseases
finance.yahoo.com - November 6 at 7:01 PM |
| AC Immune (ACIU) Expected to Beat Earnings Estimates: Should You Buy?
finance.yahoo.com - November 5 at 1:09 PM |
 | AC Immune SA Common Stock (ACIU) Advanced Charting
www.nasdaq.com - October 28 at 7:19 PM |
| AC Immune SA Common Stock (ACIU) Real-Time Quotes
www.nasdaq.com - October 28 at 2:19 PM |
| AC Immune to Host Key Opinion Leader Event: 'Untangling' Tau Pathology to Treat Alzheimer's and Neurodegenerative Diseases
www.marketwatch.com - October 24 at 8:04 AM |
| AC Immune to Host Key Opinion Leader Event: ‘Untangling’ Tau Pathology to Treat Alzheimer’s and Neurodegenerative Diseases
finance.yahoo.com - October 24 at 8:04 AM |
| Good news on Biogen's aducanumab stokes AC Immune, up 18% premarket
seekingalpha.com - October 22 at 12:59 PM |
| These Factors Make AC Immune SA (NASDAQ:ACIU) An Interesting Investment
finance.yahoo.com - September 25 at 4:11 PM |
| AC Immune to Earn Milestone From Lilly for Alzheimer's Drug
finance.yahoo.com - September 23 at 3:58 PM |
| AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer(TM) Program
www.marketwatch.com - September 20 at 12:47 PM |
| AC Immune earns CHF30M milestone from Eli Lilly
seekingalpha.com - September 20 at 12:47 PM |
| AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer™ Program
finance.yahoo.com - September 20 at 12:47 PM |
| 6 Small Drug Stocks in Focus Ahead of World Alzheimer's Day
finance.yahoo.com - September 20 at 12:47 PM |
| AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620
finance.yahoo.com - September 17 at 11:17 AM |
| AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson's Disease Diagnostic Imaging Agent
www.marketwatch.com - September 4 at 12:05 PM |
| AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging Agent
finance.yahoo.com - September 4 at 12:05 PM |
| Is AC Immune (NASDAQ:ACIU) Using Too Much Debt?
finance.yahoo.com - August 19 at 6:09 PM |
| AC Immune up 10% premarket on Q2 results
seekingalpha.com - August 14 at 6:00 PM |
| AC Immune Reports Q2 2019 Financial Results, Business and Clinical Update
finance.yahoo.com - August 14 at 9:01 AM |
| AC Immune collaborates with University of Pennsylvania for TDP-43 in neurodegenerative diseases
seekingalpha.com - August 12 at 9:21 AM |
| AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases
finance.yahoo.com - August 12 at 9:21 AM |
| Analysts Estimate AC Immune (ACIU) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - August 7 at 5:21 PM |
| AC Immune launches study of Alzheimer's candidate; shares up 2%
seekingalpha.com - August 1 at 11:21 AM |
| AC Immune Initiates Phase I Study for Alzheimer's Disease
finance.yahoo.com - July 18 at 5:26 PM |
| AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer(TM), an Investigational Treatment for Alzheimer's Disease
www.marketwatch.com - July 17 at 10:00 AM |
| AC Immune launches early-stage ACI-3024 study for Alzheimer’s Disease
seekingalpha.com - July 17 at 10:00 AM |
| AC Immune Hosts KOL Event and Reports Initial Interim Clinical Data for ACI-24 Vaccine to Treat Alzheimer’s Disease-like Symptoms in Subjects with Down Syndrome
finance.yahoo.com - July 11 at 9:31 AM |
